What's new

EMEA-002282-PIP01-17-M02

EMEA-002282-PIP01-17-M02

Apr 25, 2025 - 13:35
 0
EMEA-002282-PIP01-17-M02
EMEA-002282-PIP01-17-M02
Read More

Tags:

Previous Article

Chutes & Ladders—Galapagos CEO eyes exit as spinout names leader

Next Article

EMEA-002493-PIP01-18-M06

Related Posts

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

PSUSA/00000789/202406

PSUSA/00000789/202406

Feb 14, 2025  0